Stay updated on SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Sign up to get notified when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.

Latest updates to the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded revision entry v3.5.0 to the history and removed the v3.4.3 entry.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the history.SummaryDifference0.1%

- Check40 days agoChange DetectedA new revision entry has been added to the record history, documenting an update to the study status.SummaryDifference0.1%

- Check54 days agoChange DetectedThe revision adds results-related sections such as Results Posted, Outcome Measures (Results), Adverse Events, Baseline Characteristics, and Participant Flow, along with updated documentation. It also updates Study Status and other study data sections.SummaryDifference2%

- Check61 days agoChange DetectedAdded a site-wide notice about funding and operating status. Updated the revision tag from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check68 days agoChange DetectedThe history page now includes a Show glossary option, color-coded additions and deletions (green/red), and a revision footer showing 'Revision: v3.4.0'.SummaryDifference0.8%

Stay in the know with updates to SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.